Diebold Nixdorf EVP files Form 3 with zero shares

DIEBOLD NIXDORF, Inc executive Andrew Joseph Zosel filed an initial Form 3 reporting his beneficial ownership position in the company’s common stock.

Accepted by SEC EDGAR 03/17/2026 - 05:50 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DIEBOLD NIXDORF, Inc executive Andrew Joseph Zosel filed an initial Form 3 reporting his beneficial ownership position in the company’s common stock. The filing shows he holds no shares of Diebold Nixdorf common stock directly following the reported date.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Zosel Andrew Joseph

Role EVP, Chief Prod & Tech Officer

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Andrew Joseph Zosel’s Form 3 for DBD show?

The Form 3 shows that executive Andrew Joseph Zosel reported his initial beneficial ownership in Diebold Nixdorf common stock and listed zero shares held directly as of the reported date, establishing his baseline ownership disclosure as an officer.

What is Andrew Joseph Zosel’s role at Diebold Nixdorf (DBD)?

Andrew Joseph Zosel is identified as EVP, Chief Product & Technology Officer at Diebold Nixdorf. The Form 3 links this executive role to his beneficial ownership reporting obligations for the company’s common stock under U.S. securities regulations.

Does the DBD Form 3 show any insider buying or selling by Zosel?

The filing does not show any insider buying or selling. It is categorized as a holding entry with an unknown transaction code and reports total common stock holdings of zero shares following the reported date, indicating no current position in the security.

How many Diebold Nixdorf (DBD) shares does Zosel report owning?

Zosel reports total direct beneficial ownership of 0.0000 shares of Diebold Nixdorf common stock following the reported date. This establishes that, at the time of the Form 3, he did not hold any shares directly in the company.

Is there any derivative or option position disclosed for Zosel in this Form 3?

The Form 3 derivative summary is empty, indicating no reported derivative positions such as options or warrants tied to Diebold Nixdorf common stock. Only a single common stock holding entry with zero shares following the date is disclosed in the filing.

What transaction activity type is indicated in Zosel’s DBD Form 3?

The entry is labeled as a holding rather than a buy or sell transaction. The transaction direction is classified as unknown, and the transaction summary shows no buy, sell, gift, tax withholding, or exercise activity associated with this initial ownership statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zosel Andrew Joseph

(Last) (First) (Middle)

C/O DIEBOLD NIXDORF, INCORPORATED

350 ORCHARD AVENUE NE

(Street)

NORTH CANTON OH 44720

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2026

3. Issuer Name and Ticker or Trading Symbol
DIEBOLD NIXDORF, Inc [ DBD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Prod & Tech Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Elizabeth C. Radigan, Attorney-in-fact for Andrew Joseph Zosel	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.